STK3-ALK, a Novel ALK Rearrangement in Non-Small Cell Lung Cancer With Sensitivity to Tyrosine Kinase Inhibitors: A Case Report

Overview of attention for article published in Frontiers in oncology, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 8,984 followers.

STK3-ALK, a Novel ALK Rearrangement in Non-Small Cell Lung Cancer With Sensitivity to Tyrosine Kinase Inhibitors: A Case Report #lymphoma #lymsm https://t.co/z48SpPVTu3

08 Sep 2021

Reply Repost Favourite

STK3-ALK, a Novel ALK Rearrangement in Non-Small Cell Lung Cancer With Sensitivity to Tyrosine Kinase Inhibitors: A Case Report #lymphoma #lymsm https://t.co/Gp40WQ528d

07 Sep 2021

Reply Repost Favourite

New research: STK3-ALK, a Novel ALK Rearrangement in Non-Small Cell Lung Cancer With Sensitivity to Tyrosine Kinase Inhibitors: A Case Report: Anaplastic lymphoma kinase (ALK) rearrangement occurs in 5% to 8% of patients with non-small cell… https://t.co/d

20 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.